# Vivid Seats Inc.: filings

SEAT · Nasdaq · CIK 1856031 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/seat.md) · [Financials](/companies/seat/financials.md) · [Filings](/companies/seat/filings.md) · [Insiders](/companies/seat/insiders.md)

## Reports and events: 82 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 327, 8-K 47, 425 36, 424B3 31, 3 23, 10-Q 15, EFFECT 9, CORRESP 8, UPLOAD 8, DEF 14A 7, SC 13G/A 7, DEFA14A 6, S-4/A 6, 10-K 5, 144 5, POS AM 5, SC 13G 5, ARS 4, 8-K/A 3, PRE 14A 2, S-1 2, S-4 2, S-8 2, SCHEDULE 13G 2, 10-K/A 1, 25-NSE 1, 3/A 1, 424B7 1, 4/A 1, 8-A12B 1, CERT 1, D 1, POS EX 1, S-1/A 1, SCHEDULE 13D 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:15 ET | [8-K](/filings/0001193125-26-430446.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-430446 |
| 2026-08-04 | 10:58 ET | [10-Q](/filings/0001193125-26-331507.md) | Quarterly report, period 2026-06-30 | 0001193125-26-331507 |
| 2026-08-04 | 10:32 ET | [8-K](/filings/0001193125-26-331453.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331453 |
| 2026-06-15 | 20:15 ET | [8-K](/filings/0001193125-26-271103.md) | 5.07 Shareholder vote results | 0001193125-26-271103 |
| 2026-05-05 | 10:42 ET | [10-Q](/filings/0001193125-26-204975.md) | Quarterly report, period 2026-03-31 | 0001193125-26-204975 |
| 2026-05-05 | 10:39 ET | [8-K](/filings/0001140361-26-018995.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-018995 |
| 2026-04-27 | 20:15 ET | [DEF 14A](/filings/0001140361-26-017103.md) | Proxy statement, period 2026-06-09 | 0001140361-26-017103 |
| 2026-03-12 | 10:53 ET | [10-K](/filings/0001193125-26-103023.md) | Annual report, period 2025-12-31 | 0001193125-26-103023 |
| 2026-03-12 | 10:40 ET | [8-K](/filings/0001193125-26-103009.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-103009 |
| 2026-01-20 | 21:15 ET | [8-K](/filings/0001193125-26-016594.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-016594 |
| 2025-12-30 | 21:15 ET | [8-K](/filings/0001193125-25-337122.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001193125-25-337122 |
| 2025-11-07 | 22:02 ET | [SCHEDULE 13D](/filings/0001193125-25-272549.md) | Ownership report, active investor | 0001193125-25-272549 |
| 2025-11-06 | 11:36 ET | [10-Q](/filings/0001193125-25-267993.md) | Quarterly report, period 2025-09-30 | 0001193125-25-267993 |
| 2025-11-06 | 11:36 ET | [8-K](/filings/0001193125-25-267994.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-267994 |
| 2025-10-23 | 20:15 ET | [8-K/A](/filings/0001140361-25-039086.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-039086 |
| 2025-10-20 | 11:16 ET | [8-K](/filings/0001140361-25-038568.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-038568 |
| 2025-08-05 | 10:53 ET | [10-Q](/filings/0000950170-25-102376.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102376 |
| 2025-08-05 | 10:46 ET | [8-K](/filings/0000950170-25-102372.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102372 |
| 2025-07-25 | 20:16 ET | [8-K](/filings/0001140361-25-027332.md) | 5.07 Shareholder vote results | 0001140361-25-027332 |
| 2025-07-11 | 20:53 ET | [DEF 14A](/filings/0001140361-25-025657.md) | Proxy statement, period 2025-07-21 | 0001140361-25-025657 |
| 2025-06-09 | 20:15 ET | [8-K](/filings/0001140361-25-021949.md) | 5.07 Shareholder vote results | 0001140361-25-021949 |
| 2025-05-06 | 10:37 ET | [10-Q](/filings/0000950170-25-063944.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063944 |
| 2025-05-06 | 10:35 ET | [8-K](/filings/0000950170-25-063942.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063942 |
| 2025-04-21 | 20:15 ET | [DEF 14A](/filings/0001140361-25-014731.md) | Proxy statement, period 2025-06-03 | 0001140361-25-014731 |
| 2025-03-13 | 23:36 ET | [8-K/A](/filings/0000950170-25-038228.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-038228 |
| 2025-03-12 | 10:39 ET | [10-K](/filings/0000950170-25-037612.md) | Annual report, period 2024-12-31 | 0000950170-25-037612 |
| 2025-03-12 | 10:33 ET | [8-K](/filings/0000950170-25-037611.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-037611 |
| 2025-02-11 | 21:30 ET | [8-K](/filings/0001140361-25-003838.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-25-003838 |
| 2024-11-07 | 12:03 ET | [10-Q](/filings/0000950170-24-122768.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122768 |
| 2024-11-07 | 11:35 ET | [8-K](/filings/0000950170-24-122751.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-122751 |
| 2024-10-24 | 20:15 ET | [8-K](/filings/0001140361-24-044118.md) | 5.02 Departure or appointment of officers or directors | 0001140361-24-044118 |
| 2024-08-06 | 11:13 ET | [10-Q](/filings/0000950170-24-091203.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091203 |
| 2024-08-06 | 11:08 ET | [8-K](/filings/0000950170-24-091202.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-091202 |
| 2024-06-20 | 20:15 ET | [8-K](/filings/0001140361-24-030734.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-030734 |
| 2024-06-10 | 20:15 ET | [8-K](/filings/0001140361-24-029568.md) | 5.07 Shareholder vote results | 0001140361-24-029568 |
| 2024-05-07 | 11:13 ET | [10-Q](/filings/0000950170-24-053932.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053932 |
| 2024-05-07 | 11:08 ET | [8-K](/filings/0000950170-24-053927.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053927 |
| 2024-04-24 | 20:15 ET | [DEF 14A](/filings/0001140361-24-021721.md) | Proxy statement, period 2024-06-04 | 0001140361-24-021721 |
| 2024-03-08 | 00:21 ET | [10-K](/filings/0000950170-24-028243.md) | Annual report, period 2023-12-31 | 0000950170-24-028243 |
| 2024-03-05 | 11:36 ET | [8-K](/filings/0000950170-24-025361.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-025361 |
| 2024-02-09 | 21:15 ET | [8-K](/filings/0001140361-24-006725.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-006725 |
| 2024-01-09 | 21:15 ET | [DEF 14A](/filings/0001140361-24-001524.md) | Proxy statement, period 2024-02-05 | 0001140361-24-001524 |
| 2023-12-13 | 22:08 ET | [8-K](/filings/0001193125-23-294440.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-294440 |
| 2023-12-12 | 21:05 ET | [8-K](/filings/0001193125-23-293372.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-293372 |
| 2023-12-05 | 11:12 ET | [S-1](/filings/0001193125-23-288789.md) | Registration statement | 0001193125-23-288789 |
| 2023-12-05 | 11:05 ET | [8-K/A](/filings/0001193125-23-288781.md) | 9.01 Financial statements and exhibits | 0001193125-23-288781 |
| 2023-11-07 | 11:23 ET | [10-Q](/filings/0000950170-23-059732.md) | Quarterly report, period 2023-09-30 | 0000950170-23-059732 |
| 2023-11-07 | 11:18 ET | [8-K](/filings/0000950170-23-059730.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-059730 |
| 2023-08-08 | 10:33 ET | [10-Q](/filings/0000950170-23-039327.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039327 |
| 2023-08-08 | 10:15 ET | [8-K](/filings/0000950170-23-039314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039314 |

Page 1 of 2. [Older](/companies/seat/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.